Ret oncogene activation in papillary thyroid carcinoma:: Prevalence and implication on the histological parameters

被引:55
作者
Lam, AKY [1 ]
Montone, KT
Nolan, KA
Livolsi, VA
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong
[2] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
papillary carcinoma; Ret; in situ hybridization;
D O I
10.1016/S0046-8177(98)80004-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The Ref proto-oncogene is known to be rearranged in papillary carcinoma of the thyroid. The aim of this study was to investigate the in situ expression of Ret mRNA in thyroid tumors. Formalin-fixed, paraffin-embedded tissue specimens from 45 thyroid lesions were examined by in situ hybridization using manual capillary action technology (MicroProbe Staining System) and a 52-base synthetic biotmylated oligonucleotide probe complementary to the tyrosine-kinase domain of Ret proto-oncogene. The clinicopathological features of these patients with thyroid lesions also were noted. Ret was noted in 17 (43%) of 40 papillary carcinomas. In contrast, none of the three follicular carcinomas, follicular adenoma, nodular hyperplasia, and normal thyroids, showed evidence of Ref mRNA Our results showed that, in papillary thyroid carcinoma, there is an important role of Ret activation. The Ret staining could be a useful marker for papillary carcinoma. HUM PATHOL 29:565-568. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:565 / 568
页数:4
相关论文
共 36 条
[1]  
BEARHRS OH, 1992, THYROID GLAND MANUAL, P53
[2]   Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma [J].
Bongarzone, I ;
Fugazzola, L ;
Vigneri, P ;
Mariani, L ;
Mondellini, P ;
Pacini, F ;
Basolo, F ;
Pinchera, A ;
Pilotti, S ;
Pierotti, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :2006-2009
[3]  
BONGARZONE I, 1994, CANCER RES, V54, P2979
[4]   Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region [J].
Delvincourt, C ;
Patey, M ;
Flament, JB ;
Suarez, HG ;
Larbre, H ;
Jardillier, JC ;
Delisle, MJ .
CLINICAL BIOCHEMISTRY, 1996, 29 (03) :267-271
[5]   DETECTION OF RET ONCOGENE ACTIVATION IN HUMAN PAPILLARY THYROID CARCINOMAS BY INSITU HYBRIDIZATION [J].
FABIEN, N ;
PAULIN, C ;
SANTORO, M ;
BERGER, N ;
GRIECO, M ;
GALVAIN, D ;
BARBIER, Y ;
DUBOIS, PM ;
FUSCO, A .
BRITISH JOURNAL OF CANCER, 1992, 66 (06) :1094-1098
[6]  
Fugazzola L, 1996, ONCOGENE, V13, P1093
[7]  
FUGAZZOLA L, 1995, CANCER RES, V55, P5617
[8]   A NEW ONCOGENE IN HUMAN THYROID PAPILLARY CARCINOMAS AND THEIR LYMPH-NODAL METASTASES [J].
FUSCO, A ;
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
PILOTTI, S ;
PIEROTTI, MA ;
DELLAPORTA, G ;
VECCHIO, G .
NATURE, 1987, 328 (6126) :170-172
[9]   RET/PTC ACTIVATION IN HUMAN THYROID CARCINOMAS [J].
FUSCO, A ;
SANTORO, M ;
GRIECO, M ;
CARLOMAGNO, F ;
DATHAN, N ;
FABIEN, N ;
BERLINGIERI, MT ;
LI, Z ;
DEFRANCISCIS, V ;
SALVATORE, D ;
MELILLO, RM ;
PORTELLA, G ;
CERRATO, A ;
COLANTUONI, V ;
VECCHIO, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (02) :127-129
[10]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563